Hiperhomocisteinemia como factor de riesgo trombótico en pacientes con lupus eritematoso sistémico y síndrome antifosfolípido. / [Hyperhomocysteine like thrombocytic risk factor in patient with systemic lupus erythematous with antiphospholipid syndrome]
Rev. Fac. Cien Med. Univ Nac Cordoba
; 62(1): 21-5, 2005.
Article
in Spanish
| BINACIS
| ID: bin-38340
Responsible library:
AR32.1
ABSTRACT
OBJECTIVES:
to detect the prevalence of hyperhcy in SLE patients with and without antiphospholipid syndrom; to compare the Hcy levels between those patients and healthy controls and to determine the correlation between hyperhcy and antiphospholipid antibodies. PATIENTS ANDMETHODS:
we studied 44 SLE patients 17 had antiphospholipid syndrom and 27 didnt have it, and we compared them to 24 healthy controls. All of them where checked clinically and with laboratory tests like anticardiolypin antibodies, lupus anticoagulant and Hcy. Hcy > 9 was considered abnormal. Patient who had hyperhcy were treated with folic acid+vitB6+vitB12 a month along. Statisticalanalysis:
cualytative variables chi square or Fischers; cuantitative variables Students T test or Mann-Whitneys test. RESULTS AND CONCLUTIONS there were 35 trombotic manifestations in 44 patients. Hyperhcy was present in 27 SLE patients (61,4
Search on Google
Collection:
National databases
/
Argentina
Database:
BINACIS
Type of study:
Etiology study
/
Risk factors
Language:
Spanish
Journal:
Rev. Fac. Cien Med. Univ Nac Cordoba
Year:
2005
Document type:
Article